町田 進／Susumu Machida
Corporate Officer, Vice President
- Since joining a major engineering company (Chiyoda Corporation) in 1989, he has been engaged in projects for pharmaceutical manufacturing facilities. Engaged mainly in upstream and downstream processes of biopharmaceutical facilities, as well as in pharmaceutical engineering of various other pharmaceutical manufacturing facilities such as sterile formulations, solid dosage forms, synthetic APIs as an engineer and project manager.
- He was also involved in validation activities, and was involved in the preparation for the establishment of the ISPE Japan Headquarters. He also coordinated the Japanese review of the Baseline Guide for biopharmaceutical API and received an Acknowledgement from Mr. Robert P. Best, President CEO of ISPE International Headquarters.
- He joined CM Plus Japan in 2010.
- At CM Plus, he was in charge of animal cell culture PJ (4 projects from 3 domestic companies), synthetic API PJ (2 projects from 2 domestic companies), cell processing center PJ (4 projects from 2 domestic companies), sterile drug product PJ (3 projects from 2 domestic companies, 2 projects from 2 overseas companies), solid formulation Pj (5 projects from 3 domestic companies), chemical hazard formulation PJ (2 projects from 2 domestic companies), SOP creation / CSV review operations (3 projects from 2 domestic companies) until 2019.
- He was appointed as a member of the Board in September 2013 and further promoted as Managing Director in September 2014. From April 2018, he is Executive Vice President of CM Plus Japan.
© CM Plus Corporation All rights reserved